Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bio-Inspired Investigation on Dual-Pore Synergistic Effect in Zirconium Supramolecular Framework for Ethane/Ethylene Separation.

Inorganic chemistry·2026
Same author

Synthesis of Multivariate Indolo[3,2-<i>b</i>]carbazole-Based Zr-MOFs via <i>In Situ</i> Synthetic Modification for Propane Recovery from Simulated Natural Gas.

Inorganic chemistry·2025
Same author

A multivariate analysis of the impact of HIV infection on the risk of osteoporosis based on the NHANES database.

Medicine·2025
Same author

Copper pyrithione exposure-induced copper accumulation compromises mouse oocyte maturation.

Journal of environmental management·2025
Same author

Response of photosynthetic capacity of <i>Larix gmelinii</i> needles to climate warming.

Ying yong sheng tai xue bao = The journal of applied ecology·2025
Same author

GNPAT/USP30 Stabilizes DRP1 Protein to Promote Mitochondrial Fission and Functional Damage in COPD Progression.

The Kaohsiung journal of medical sciences·2025
Same journal

Mechanistic constraints in dengue severity: a systematic review with evidence stratification and agent-based evaluation of logical sufficiency.

Frontiers in immunology·2026
Same journal

Circadian control of immune homeostasis in cardiovascular health and disease.

Frontiers in immunology·2026
Same journal

An IHC-derived TLS-CD8-macrophage immune niche score predicts major pathological response to neoadjuvant chemoimmunotherapy in resectable NSCLC.

Frontiers in immunology·2026
Same journal

AF6 orchestrates macrophage polarization via JAK2-STAT3 signaling and supports intestinal regeneration by stimulating stem cell proliferation.

Frontiers in immunology·2026
Same journal

Restoring immune homeostasis in the spinal microenvironment: targeting mechano-inflammation and immunometabolic reprogramming.

Frontiers in immunology·2026
Same journal

A self-perpetuating neuron-intrinsic GSDMD-mtDNA-AIM2 inflammasome axis drives neuronal pyroptosis and cognitive impairment after traumatic brain injury.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K

Plasmablastic lymphoma: current knowledge and future directions.

Ji-Wei Li1, Hong-Ling Peng2, Xiao-Yan Zhou3,4,5

  • 1Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Immunology
|February 28, 2024
PubMed
Summary
This summary is machine-generated.

Plasmablastic lymphoma (PBL) is an aggressive cancer. This review summarizes current knowledge on PBL, including its features, molecular profile, and treatment strategies for better patient outcomes.

Keywords:
HIVimmunotherapymolecular profilesplasmablastic lymphomatreatment

More Related Videos

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.7K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.7K

Related Experiment Videos

Last Updated: Jul 2, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.7K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.7K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Plasmablastic lymphoma (PBL) is an aggressive non-Hodgkin lymphoma.
  • PBL is strongly associated with HIV infection and immunodeficiency but also occurs in immunocompetent individuals.
  • PBL exhibits distinct clinical, pathological, and molecular features.

Purpose of the Study:

  • To review the epidemiology of PBL.
  • To summarize clinical, pathological, and molecular features of PBL.
  • To discuss diagnostic and therapeutic strategies for PBL.

Main Methods:

  • Literature review of studies on Plasmablastic lymphoma.
  • Analysis of clinical and pathological data.
  • Review of molecular profiling studies, including gene expression analysis.

Main Results:

  • PBL shows plasmablastic morphology and plasma cell marker expression.
  • Clinicopathologic features differ between HIV-positive and HIV-negative patients.
  • Frequent c-MYC rearrangement and BCR signaling pathway downregulation are key molecular findings.

Conclusions:

  • PBL is an aggressive lymphoma with unique characteristics.
  • Understanding molecular features aids in diagnosis and treatment.
  • Despite advances, PBL prognosis remains poor, necessitating novel therapeutic approaches.